Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
This study is ongoing, but not recruiting participants.
Study NCT00118365 Information provided by National Cancer Institute (NCI)
First Received: July 8, 2005 Last Updated: May 12, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Colorectal Neoplasms
Precancerous Conditions
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
eflornithine
sulindac
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
Chao Family Comprehensive Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
